-
Core Evidence
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Core Evidence
(132,222) Views
Editor in Chief Gulshan Sharma, MD
1555-175X
ISSN: 1555-175X (online) 1555-1741 (print)
Core Evidence evaluates the evidence underlying the potential place in therapy of drugs throughout their development lifecycle from preclinical to postlaunch. The focus of each review is to evaluate the case for a new drug or class in outcome terms in specific indications and patient groups.
Note to authors: Before submitting your paper to Core Evidence please ensure you include the Levels of Evidence.
Indexed online:
- CINAHL
- EMBase, Scopus and the Elsevier bibliographic databases
- Accepted for indexing on PubMed
- OAIster - The Open Access Initiative
- ResearchGATE scientific network
Article Processing Statistics:
15 From submission of manuscript to first editorial decision (including peer-review)
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
